Vaccines for the control of HIV/AIDS. (Q34017996)

30 July 2017

1 reference

title

Vaccines for the control of HIV/AIDS. (English)

1 reference

30 July 2017

Gotch F

1

1 reference

30 July 2017

Rutebemberwa A

2

1 reference

30 July 2017

Jones G

3

1 reference

30 July 2017

Imami N

4

1 reference

30 July 2017

Gilmour J

5

1 reference

30 July 2017

Kaleebu P

6

1 reference

30 July 2017

Whitworth J

7

1 reference

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

Tropical Medicine and International Health

30 July 2017

1 reference

30 July 2017

5

1 reference

30 July 2017

7

1 reference

30 July 2017

A16-21

1 reference

Live attenuated SIV--a model of a vaccine for AIDS.

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Poliomyelitis eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Particle-mediated nucleic acid immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Nucleic acid vaccines: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Replication-defective HIV as a vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00593.X

10.1046/J.1365-3156.2000.00593.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference